Join
Live feed
·
PRReleasevia Quantisnow
Foghorn Therapeutics Inc. logo
Eli Lilly and Company logo

Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform

ByQuantisnow·Wall Street's wire, on your screen.
FHTX· Foghorn Therapeutics Inc.LLY· Eli Lilly and Company
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FHTX (Foghorn Therapeutics Inc.), LLY (Eli Lilly and Company) and more on Quantisnow.